Vertex Pharmaceuticals to offer 7 million shares in public offering

Vertex Pharmaceuticals, a biotechnology company, has announced that it intends to offer, subject to market and other conditions, 7 million shares of its common stock in an underwritten public offering under an automatically effective shelf registration statement on file with the Securities and Exchange Commission.